Latest News by Industry
WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — ImmunoGen Inc. (IMGN) on Friday reported a loss of $41 million in its first quarter.
On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of 16 cents.
The results exceeded Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.
The drug developer posted revenue of $49.9 million in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected $21.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a IMGN">Zacks stock report on IMGN at https://www.zacks.com/ap/IMGN